Nanjing Medlander Medical Technology Co.,Ltd. (SHA:688273)

Market Cap	4.33B +80.6%
Revenue (ttm)	431.59M +1.7%
Net Income	102.06M +0.5%
EPS	1.04 +1.2%
Shares Out	97.81M
PE Ratio	42.45
Forward PE	n/a
Dividend	0.60 (1.38%)
Ex-Dividend Date	Nov 27, 2025

Volume	2,351,686
Average Volume	1,617,962
Open	42.56
Previous Close	43.48
Day's Range	41.55 - 44.53
52-Week Range	23.25 - 61.22
Beta	0.05
RSI	50.52
Earnings Date	Apr 16, 2026

About SHA:688273

Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, manufacture, sale, and service of pelvic floor rehabilitation equipment and related products in China and internationally. It offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vaginal electrodes, rectal electrodes, vaginal probes, etc. The company also provides pelvic floor muscle rehabilitation, biological feedback and stimulation...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 566
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688273

Financial Performance

In 2025, SHA:688273's revenue was 431.59 million, an increase of 1.66% compared to the previous year's 424.55 million. Earnings were 102.06 million, an increase of 0.47%.